Myriad Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-21,000
Closed -$2.48M 114
2021
Q4
$2.48M Sell
21,000
-5,700
-21% -$674K 0.27% 58
2021
Q3
$3.58M Buy
+26,700
New +$3.58M 0.37% 53